Tandem Diabetes Care (TNDM) Total Debt (2013 - 2025)

Tandem Diabetes Care's (TNDM) quarterly Total Debt came in at $40.7 million in Q1 2025, little changed on a QoQ basis from $40.7 million in Q4 2024.

Tandem Diabetes Care (TNDM) Total Debt (2013 - 2025) Analysis & Trends

Tandem Diabetes Care (TNDM) has 8 years of Total Debt data on file, last reported at $40.7 million in Q1 2025.

Quarterly Total Debt changed N/A year-over-year to $40.7 million in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $40.7 million (changed N/A YoY) and the FY2024 annual result came in at $40.7 million, changed N/A from the prior year.
Total Debt was little changed at $40.7 million in Q1 2025, from $40.7 million in the prior quarter.
In the past five years, Total Debt ranged from a high of $40.7 million in Q1 2025 to a low of $40.5 million in Q2 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Total Debt (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn	32.61 Bn
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn	14.94 Bn
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn	27.96 Bn
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn	12.62 Bn
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn	598.70 Mn
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn	-
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn	10.10 Bn
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn	8.68 Bn
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn	1.89 Bn
10	Tandem Diabetes Care	1.56 Bn	1.10 Bn	144.78 Mn	-

Download Data